Table 4.
Pearson’s correlation analyses between log IL-8 and HRQoL variables.
QoL variable | Pearson’s r | P-value |
---|---|---|
EORTC QLQ-C30 | ||
C30 Physical functioning | –0.275 | <0.0001 |
C30 Role functioning | –0.305 | <0.0001 |
C30 Emotional functioning | –0.096 | 0.043 |
C30 Cognitive functioning | –0.069 | 0.1441 |
C30 Social functioning | –0.244 | <0.0001 |
C30 Global QoL | –0.25 | <0.0001 |
C30 Fatigue | 0.311 | <0.0001 |
C30 Nausea/vomiting | 0.194 | <0.0001 |
C30 Pain | 0.217 | <0.0001 |
C30 Dyspnoea | 0.177 | 0.0002 |
C30 Insomnia | 0.165 | 0.0005 |
C30 Appetite loss | 0.322 | <0.0001 |
C30 Constipation | 0.024 | 0.6186 |
C30 Diarrhea | 0.116 | 0.0146 |
C30 Financial difficulty | 0.208 | <0.0001 |
C30 index-score | 0.306 | <0.0001 |
EORTC QLQ-HCC18 | ||
HCC18 Fatigue | 0.306 | <0.0001 |
HCC18 Body image | 0.267 | <0.0001 |
HCC18 Jaundice | 0.13 | 0.006 |
HCC18 Nutrition | 0.317 | <0.0001 |
HCC18 Pain | 0.164 | 0.0005 |
HCC18 Fever | 0.089 | 0.0619 |
HCC18 Sex life | 0.138 | 0.0034 |
HCC18 Abdominal swelling | 0.29 | <0.0001 |
HCC18 index-score | 0.321 | <0.0001 |
Abbreviations: EORTC, European Organization for Research and Treatment of Cancer; HCC, hepatocellular carcinoma; HRQoL, health-related quality of life; QoL, quality of life.